These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 16310433

  • 1. Effect of glucose-insulin-potassium infusion on myocardial damage due to percutaneous coronary revascularization.
    Yazici M, Demircan S, Durna K, Yasar E, Acar Z, Sahin M.
    Am J Cardiol; 2005 Dec 01; 96(11):1517-20. PubMed ID: 16310433
    [Abstract] [Full Text] [Related]

  • 2. Effects of glucose-insulin-potassium infusion on myocardial perfusion and left ventricular remodeling in patients treated with primary angioplasty for ST-elevation acute myocardial infarction.
    Bucciarelli-Ducci C, Bianchi M, De Luca L, Battagliese A, Di Russo C, Proietti P, Vizza CD, Fedele F.
    Am J Cardiol; 2006 Nov 15; 98(10):1349-53. PubMed ID: 17134627
    [Abstract] [Full Text] [Related]

  • 3. Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting.
    Ranasinghe AM, Quinn DW, Pagano D, Edwards N, Faroqui M, Graham TR, Keogh BE, Mascaro J, Riddington DW, Rooney SJ, Townend JN, Wilson IC, Bonser RS.
    Circulation; 2006 Jul 04; 114(1 Suppl):I245-50. PubMed ID: 16820580
    [Abstract] [Full Text] [Related]

  • 4. [Effect of high dose glucose-insulin-potassium infusion in patients with acute ST-segment elevation myocardial infarction: analysis of 7510 patients in China as part of CREATE-ECLA study].
    Yang YM, Zhu J, Tan HQ, Liang Y, Zhang Y, Li Y, Li JD, Liu LS, National Coordinator Office of CREATE in China.
    Zhonghua Yi Xue Za Zhi; 2008 Jul 08; 88(26):1806-10. PubMed ID: 19040013
    [Abstract] [Full Text] [Related]

  • 5. Effects of glucose-insulin-potassium solution added to reperfusion treatment in acute myocardial infarction.
    Türel B, Gemici K, Baran I, Yeşilbursa D, Güllülü S, Aydinlar A, Serdar A, Kazazoğlu AR, Kumbay E, Cordan J.
    Anadolu Kardiyol Derg; 2005 Jun 08; 5(2):90-4. PubMed ID: 15939681
    [Abstract] [Full Text] [Related]

  • 6. The effect of glucose-insulin-potassium treatment on myocardial oxidative stress in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
    Demircan S, Yazici M, Diraman E, Demircan G, Kilicaslan F, Durna K, Acar Z, Eren Z.
    Coron Artery Dis; 2008 Mar 08; 19(2):99-104. PubMed ID: 18300746
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. One year outcomes after glucose-insulin-potassium in ST elevation myocardial infarction. The Glucose-insulin-potassium study II.
    Rasoul S, Ottervanger JP, Timmer JR, Svilaas T, Henriques JP, Dambrink JH, van der Horst IC, Zijlstra F.
    Int J Cardiol; 2007 Oct 31; 122(1):52-5. PubMed ID: 17223212
    [Abstract] [Full Text] [Related]

  • 9. Intravenous glucose-insulin-potassium during off-pump coronary artery bypass surgery does not reduce myocardial injury.
    Shim YH, Kweon TD, Lee JH, Nam SB, Kwak YL.
    Acta Anaesthesiol Scand; 2006 Sep 31; 50(8):954-61. PubMed ID: 16923090
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Glucose-insulin-potassium and reperfusion in acute myocardial infarction: rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2).
    van der Horst IC, Timmer JR, Ottervanger JP, Bilo HJ, Gans RO, de Boer MJ, Zijlstra F, GIPS Investigators.
    Am Heart J; 2005 Apr 31; 149(4):585-91. PubMed ID: 15990738
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Glucose-insulin-potassium infusion in acute myocardial infarction: a hemodynamic study.
    Bergstra A, Svilaas T, van den Heuvel AF, van der Horst IC, Zijlstra F.
    Am Heart J; 2006 Feb 31; 151(2):345-51. PubMed ID: 16442897
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Glucose-insulin-potassium infusion as adjunctive therapy in myocardial infarction: current evidence and potential mechanisms.
    Timmer JR, van der Horst IC, Ottervanger JP, De Luca G, van 't Hof AW, Bilo HJ, Zijlstra F.
    Ital Heart J; 2004 Oct 31; 5(10):727-31. PubMed ID: 15626267
    [Abstract] [Full Text] [Related]

  • 17. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events.
    Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS.
    Circulation; 2004 Mar 30; 109(12):1497-502. PubMed ID: 15006999
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of modified glucose-insulin-potassium on free fatty acids, matrix metalloproteinase, and myoglobin in ST-elevation myocardial infarction.
    Chaudhuri A, Janicke D, Wilson M, Ghanim H, Wilding GE, Aljada A, Dandona P.
    Am J Cardiol; 2007 Dec 01; 100(11):1614-8. PubMed ID: 18036357
    [Abstract] [Full Text] [Related]

  • 20. Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial.
    Quinn DW, Pagano D, Bonser RS, Rooney SJ, Graham TR, Wilson IC, Keogh BE, Townend JN, Lewis ME, Nightingale P, Study Investigators.
    J Thorac Cardiovasc Surg; 2006 Jan 01; 131(1):34-42. PubMed ID: 16399292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.